Related Experiment Video
Updated: Sep 5, 2025

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
Published on: June 26, 2018
Multi-Modal Single-Cell Sequencing Identifies Cellular Immunophenotypes Associated With Juvenile Dermatomyositis
Jessica Neely1, George Hartoularos2,3,4, Daniel Bunis5,6
1Division of Pediatric Rheumatology, Department of Pediatrics, University of California San Francisco School of Medicine, San Francisco, CA, United States.
Juvenile dermatomyositis (JDM) involves immune cell changes, including altered monocytes and expanded B cells. An interferon gene signature across cell types correlates with JDM disease activity, offering new therapeutic targets.
Area of Science:
- Immunology
- Genomics
- Rare Diseases
Background:
- Juvenile dermatomyositis (JDM) is a rare autoimmune disease lacking sufficient biomarkers and effective treatments.
- Understanding the specific immune cells and genetic factors driving JDM is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the immunophenotypes and cell-specific gene expression patterns associated with JDM disease activity.
- To identify potential biomarkers and therapeutic targets by analyzing immune cells at single-cell resolution.
Main Methods:
- Multiplexed RNA and protein single-cell sequencing was performed on peripheral blood mononuclear cells (PBMCs) from treatment-naïve JDM (TN-JDM) patients and patients with inactive disease.
- Analysis included 55,564 cells, examining cell populations, differential gene expression, and protein markers.
Main Results:
- TN-JDM cells showed distinct clustering within monocyte, NK, CD8+ effector T, and naïve B cell populations.
- An interferon (IFN) gene signature was over-expressed across all cell types in TN-JDM, correlating with disease activity, particularly in cytotoxic cells.
- CD16+ monocytes in TN-JDM exhibited the highest IFN gene score and an inflammatory, antigen-presenting phenotype.
- Expanded transitional B cells in TN-JDM displayed a unique transcriptomic signature with altered CD24, CD5, and CD39 protein expression.
Conclusions:
- This study provides novel cellular and molecular insights into immune dysregulation in JDM.
- The identified IFN gene signature and specific immune cell alterations (e.g., CD16+ monocytes, transitional B cells) represent potential therapeutic targets for JDM.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Cell-mediated Immune Responses
Cells of the Adaptive Immune Response
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

